Sean Senn

Art and Tactics

Too many tacticians, and too few artists. Too many managers, lawyers and consultants, and too few actual innovators. It seems like every time I’m at these ‘innovation’ conferences, everyone that I meet, every panel I hear, has all kinds of advice on how to build and run a biotech start up, or has a new…

Purpose.

Immix’s lead cancer therapeutic is in clinical trials. When I hear the words “clinical trial,” the first thing that immediately leaps into my head is the smell. More specifically, a memory of the smell of the hospital where my dad was being treated for cancer as a participant in a clinical trial until he passed…